EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kinase Inhibitors can Change Protonation or Tautomeric State upon Binding

Gehan A Ranepura, Saqibul I Chowdhury, Elizabeth A Rosenzweig, Ariën S Rustenburg, Raquel López-Ríos de Castro, Junjun Mao, John D Chodera iD, Sukrit Singh iD, M R Gunner

Journal of Chemical Information and Modeling · 09.11.2026 · 66 (21) · 14159-14173

DOI: 10.1021/acs.jcim.6c02792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 16.10.2026. Verfasst von Gehan A Ranepura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. Program in Physics, The Graduate Center, City University of New York, New York, New York10016, United States. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Protons, Protein Kinases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Damon Runyon Cancer Research Foundation, Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The binding affinity of a ligand to a protein is influenced by the protonation and tautomeric states of both partners. However, this relationship remains under-investigated due to the limited availability of computational tools capable of treating charge and tautomer states together in a scalable manner to study clinically relevant systems. Here, we use multi-conformation continuum electrostatics (MCCE) to calculate the protonation and tautomer distributions of nine kinase domains bound to 18 FDA-approved inhibitors across 37 cocrystal structures, while considering their Boltzmann-ensemble. The full pipeline was repeated in triplicate, so that every reported value carries a measured run-to-run uncertainty. Our simulations show that protein net charge and proton distribution remain largely stable even upon binding charged inhibitors. Our results find that individual inhibitor charges are dynamic, frequently increasing or decreasing upon binding a specific protein target. We observe that kinase-inhibitor binding shifts the relative probabilities of low-energy states (ΔG < 2.8 kcal/mol), but does not increase the probability of higher-energy states in the bound form. By considering all low-energy charge states and tautomers, we identify when two solution-state tautomers of nearly equal population resolve upon binding into a single state, creating free energy differences of up to 3.5 kcal/mol between tautomers, and in some complexes differences beyond the resolution of the sampling. In turn, we find that minority species can become the dominant component in the bound state, emphasizing the necessity of considering ensemble-wide protonation and tautomer states to accurately predict protein–ligand binding energetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsProtonsProtein KinasesProtein BindingThermodynamicsStatic ElectricityLigandsMolecular Dynamics SimulationIsomerism

Substanzen

Protein Kinase InhibitorsProtonsProtein KinasesLigands

Autor:innen und Institutionen

  • Ph.D. Program in Physics, The Graduate Center, City University of New York, New York, New York10016, United States.
  • Department of Physics, City College of New York, New York, New York10031, United States.
  • Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York10065, United States.
  • Graduate Program in Physiology, Biophysics, and Systems Biology, Weill Cornell Medical College, New York, New York10065, United States.
  • Department of Physics, Freie Universität Berlin, Arnimallee 14, Berlin14195, Germany.
  • Benjamin Levich Institute for Physico-Chemical Hydrodynamics, City College of New York, New York, New York10031, United States.

ORCID-Profile: John D Chodera, Sukrit Singh

Förderung

  • NCI NIH HHS
  • Damon Runyon Cancer Research Foundation
  • Horizon 2020 Framework Programme
  • Division of Molecular and Cellular Biosciences
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Ranepura, G. A., Chowdhury, S. I., Rosenzweig, E. A., Rustenburg, A. S., López-Ríos de Castro, R., Mao, J., Chodera, J. D., Singh, S., & Gunner, M. R. (2026). Kinase Inhibitors can Change Protonation or Tautomeric State upon Binding. Journal of Chemical Information and Modeling, 66(21), 14159-14173. https://doi.org/10.1021/acs.jcim.6c02792

Vancouver

Ranepura GA, Chowdhury SI, Rosenzweig EA, Rustenburg AS, López-Ríos de Castro R, Mao J, et al. Kinase Inhibitors can Change Protonation or Tautomeric State upon Binding. Journal of Chemical Information and Modeling. 2026;66(21):14159-14173. doi:10.1021/acs.jcim.6c02792

BibTeX
@article{Ranepura2026,
  author = {Ranepura, Gehan A and Chowdhury, Saqibul I and Rosenzweig, Elizabeth A and Rustenburg, Ariën S and López-Ríos de Castro, Raquel and Mao, Junjun and Chodera, John D and Singh, Sukrit and Gunner, M R},
  title = {Kinase Inhibitors can Change Protonation or Tautomeric State upon Binding},
  journal = {Journal of Chemical Information and Modeling},
  year = {2026},
  volume = {66},
  number = {21},
  pages = {14159--14173},
  doi = {10.1021/acs.jcim.6c02792}
}
Kostenlos starten →